tiprankstipranks
Advertisement
Advertisement

HK:2410 Stock Latest News

TYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
Company AnnouncementsTYK Medicines Narrows Annual Loss as R&D Spending Holds Steady and Governance Changes Loom
10d ago
2410
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
PremiumCompany Announcements
TYK Medicines to Present Five Novel Cancer Drug Programs at 2026 AACR Meeting
14d ago
2410
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
PremiumCompany Announcements
TYK Medicines Completes Full H-Share Conversion to Boost Market Liquidity
1M ago
2410
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
PremiumCompany Announcements
TYK Medicines Dilutes Stake in TYK Bio via RMB83.5 Million Capital Injection
1M ago
2410
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
PremiumCompany Announcements
TYK Medicines Wins Approval for Full H-Share Circulation in Hong Kong
2M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
PremiumCompany AnnouncementsTYK Medicines’ Lung Cancer Drug Asandeutertinib NDA Accepted by China’s NMPA
2M ago
2410
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
Premium
Company Announcements
TYK Medicines’ Lung Cancer Drug Asandeutertinib Granted Priority Review in China
2M ago
2410
TYK Medicines Wins CSRC Nod for Conversion of 4.6 Million Unlisted Shares into H Shares
Premium
Company Announcements
TYK Medicines Wins CSRC Nod for Conversion of 4.6 Million Unlisted Shares into H Shares
3M ago
2410
TYK Medicines Secures Zhejiang Drug Manufacturing License to Support Cancer Drug Commercialisation
PremiumCompany Announcements
TYK Medicines Secures Zhejiang Drug Manufacturing License to Support Cancer Drug Commercialisation
3M ago
2410
TYK Medicines’ Lung Cancer Drug Candidate Proposed for Priority Review Amid Share Volatility
PremiumCompany Announcements
TYK Medicines’ Lung Cancer Drug Candidate Proposed for Priority Review Amid Share Volatility
3M ago
2410
TYK Medicines Strengthens Board with New Appointments
PremiumCompany Announcements
TYK Medicines Strengthens Board with New Appointments
4M ago
2410
TYK Medicines, Inc. Approves Key Resolutions at 2025 EGM
PremiumCompany Announcements
TYK Medicines, Inc. Approves Key Resolutions at 2025 EGM
5M ago
2410
TYK Medicines Reports Promising Clinical Data for CDK Inhibitors at ESMO 2025
PremiumCompany AnnouncementsTYK Medicines Reports Promising Clinical Data for CDK Inhibitors at ESMO 2025
6M ago
2410
TYK Medicines, Inc Proposes Structural Reforms and Incentive Scheme
Premium
Company Announcements
TYK Medicines, Inc Proposes Structural Reforms and Incentive Scheme
6M ago
2410
TYK Medicines, Inc Announces Key Governance Changes at Upcoming EGM
Premium
Company Announcements
TYK Medicines, Inc Announces Key Governance Changes at Upcoming EGM
6M ago
2410
TYK Medicines, Inc. Strengthens Governance with New Audit Committee
PremiumCompany Announcements
TYK Medicines, Inc. Strengthens Governance with New Audit Committee
6M ago
2410
TYK Medicines Announces Book Closure for EGM on Articles Amendment
PremiumCompany Announcements
TYK Medicines Announces Book Closure for EGM on Articles Amendment
6M ago
2410
TYK Medicines Faces Temporary Non-Compliance Following Director Resignation
PremiumCompany Announcements
TYK Medicines Faces Temporary Non-Compliance Following Director Resignation
7M ago
2410
TYK Medicines Announces Board Composition and Committee Roles
PremiumCompany Announcements
TYK Medicines Announces Board Composition and Committee Roles
7M ago
2410
TYK Medicines Enhances Treasury Operations with Strategic Investments
PremiumCompany AnnouncementsTYK Medicines Enhances Treasury Operations with Strategic Investments
7M ago
2410
TYK Medicines Announces Board Composition and Roles
Premium
Company Announcements
TYK Medicines Announces Board Composition and Roles
7M ago
2410
TYK Medicines Reports Reduced Losses in H1 2025
Premium
Company Announcements
TYK Medicines Reports Reduced Losses in H1 2025
7M ago
2410

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >